Is teriparatide injection necessary for long-term use?
Teriparatide injection does not require long-term use. It is usually used as a short-term treatment for osteoporosis. Its main function is to reduce the risk of fractures by promoting bone formation and increasing bone density. Teriparatide is usually used in patients who have experienced a fracture or are at higher risk for fracture, especially if other drugs (such as bisphosphonates) are not working as well or are not tolerated. According to treatment guidelines, the use of teriparatide is generally recommended for 1 to 2 years.
In clinical applications, the treatment course of teriparatide is usually shorter because its main effect is to stimulate bone formation, and using it for too long may increase the risk of side effects. Studies have shown that bone density improved significantly and the risk of fractures decreased after one or two years of treatment with teriparatide. To avoid potential risks associated with long-term use, patients are often advised to switch to other maintenance therapies after the treatment period, such as bisphosphonates, selective estrogen receptor modulators (SERM), or other anti-osteoporotic drugs.

Although the treatment period of teriparatide is short, doctors usually closely monitor the patient's bone density, blood calcium levels, and whether adverse reactions occur during treatment. If, after the treatment period, the patient's bone density remains low and the risk of fracture is high, the doctor may recommend continued use of other medications for long-term management of osteoporosis. Therefore, although teriparatide itself is not suitable for long-term use, it may be part of a longer-term treatment regimen as part of short-term intensive therapy.
In general, teriparatide injection does not require long-term use, and the regimen is usually adjusted or switched after short-term treatment. During treatment, patients should regularly check bone density and related health indicators according to the doctor's recommendations to ensure the best treatment effect and avoid unnecessary risks.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)